MarketsandMarkets projects that the market for chromatography resin in drug discovery will grow from USD 290.7 Million in 2017 to USD 401.1 Million by 2022, at a CAGR of 6.65% from 2017 to 2022. The growth of this market is expected to be driven by the rising demand from pharmaceuticals and biotechnology verticals.
Seattle, WA -- (SBWIRE) -- 06/21/2017 -- The report "Chromatography Resin Market in Drug Discovery by Type (Natural, Synthetic, Inorganic Media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Multi-Modal), and Region - Global Forecast to 2022", The market for chromatography resin in drug discovery is projected to grow from USD 290.7 Million in 2017 to USD 401.1 Million by 2022, at a CAGR of 6.65% from 2017 to 2022.
Browse 101 market data tables and 37 figures spread through 147 pages and in-depth TOC on "Chromatography Resin Market in Drug Discovery - Global Forecast to 2022"
Early buyers will receive 10% customization on this report.
Factors such as the growing demand for therapeutic antibodies and rising R&D in biopharmaceuticals are driving the market.
Ion exchange chromatography segment accounted for the largest share of the chromatography resin market in drug discovery.
The ion exchange segment accounted for the largest share in 2016, in terms of volume, and is projected to grow at a considerable rate during the forecast period. Ion exchange chromatography technique is widely used for biopharmaceutical purification processes. It is used in combination with other techniques, wherein the use of protein as resins is not a commercially preferred option. This has led to the high demand for ion exchange resins in the past decade.
Request for the Sample PDF of Report @ http://www.marketsandmarkets.com/pdfdownload.asp?id=29294329
Natural polymer segment accounted for the largest share of the chromatography resin market in drug discovery.
Natural polymer was the largest segment of the chromatography resin market in drug discovery, in terms of value, in 2016. Agarose, cellulose, and dextran are the natural polymers that are most commonly used as resins in chromatography applications. The major advantage of these natural polymers is their hydrophilic nature, as they have a large number of hydroxyl groups in their structure. These provide functional sites for the coupling of suitable ligands.
North America is the largest market for chromatography resin in drug discovery.
On the basis of region, the chromatography resin market in drug discovery is segmented into North America, Europe, Asia-Pacific, and RoW. North America is the key market for chromatography resin in drug discovery. The U.S. is the leading market for chromatography resin in drug discovery in the region, followed by Canada. Strong growth in the monoclonal antibody therapeutics market of the region drives the demand for chromatography resin in drug discovery in this region.
Make an Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=29294329
Major players operating in the chromatography resin market in drug discovery are General Electric Company (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Tosoh Corporation (Japan). These companies are adopting strategies such as new product launches, expansions, and contracts & agreements to strengthen their market position, widen their product portfolio, and increase their customer base.
Browse Related Reports:
Chromatography Resin Market by Type (Natural, Synthetic, Inorganic media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Multi-Modal), Application (Pharmaceutical & Biotechnology, Food & Beverage) - Global Forecast to 2021
Chromatography Instruments Market by System (LC (HPLC, UHPLC, Flash), GC, Other Components (Autosamplers, Detectors, Fraction Collectors), Consumable (Reverse Phase Columns, Syringe Filters, Vials) - Analysis & Global Forecasts to 2020
Subscribe Reports from Chemicals & Materials Domain http://www.marketsandmarkets.com/Knowledgestore.asp
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/chemical
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
For more information, please visit http://www.marketsandmarkets.com